Patent 7390619 was granted and assigned to Maxygen, Inc. on June, 2008 by the United States Patent and Trademark Office.
This invention provides methods for obtaining molecules that can modulate an immune response, and immunomodulatory molecules obtained using the methods. The molecules find use, for example, in the tailoring of an immune response induced by a genetic vaccine for a desired purpose.